TRIMBLE INC. (TRMB)
Measuring & Controlling Devices, NEC · Healthcare · $11.8B
Intrinsic Value (Consensus)
$25.90
Current Price
$50.78
Margin of Safety
-49%
49% Above Intrinsic Value
Value: $26
Price: $51
Valuation Model Estimates
Current Price: $50.78
DCF (Discounted Cash Flow)
$19.75
Graham Number
$31.58
Earnings Power Value
$17.09
Relative Value (P/E)
$35.20
Dividend Discount Model
Not applicable
—
Consensus Value
$25.90
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
50
Profitability
15/25
Strength
24/25
Valuation
7/25
Growth
4/25
Financial Health Signals
Declining revenue — top line is shrinking
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $1.76
- EPS (Forward)
- $1.80
- Book Value
- $25.19
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 7.3%
- Debt/Equity
- 24%
- Revenue Growth
- -2.6%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance